C07K 16/084
Papillomaviridae
Official title: Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
C07K16/084 (Papillomaviridae) appears on 126 US grants and 188 published applications in this corpus.
Search patents in C07K- Granted patents
- 126
- Published applications
- 188
- Assignees
- 133
- Inventors
- 374
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 2 |
| 2003 | 2 | 5 |
| 2004 | 2 | 8 |
| 2005 | 2 | 4 |
| 2006 | 3 | 7 |
| 2007 | 3 | 4 |
| 2008 | 5 | 3 |
| 2009 | 2 | 5 |
| 2010 | 1 | 3 |
| 2011 | 4 | 4 |
| 2012 | 1 | 7 |
| 2013 | 1 | 6 |
| 2014 | 3 | 3 |
| 2015 | 3 | 13 |
| 2016 | 4 | 12 |
| 2017 | 9 | 3 |
| 2018 | 10 | 8 |
| 2019 | 6 | 14 |
| 2020 | 8 | 10 |
| 2021 | 8 | 10 |
| 2022 | 5 | 9 |
| 2023 | 7 | 18 |
| 2024 | 6 | 13 |
| 2025 | 5 | 13 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neutralizing monoclonal anti-VP1 antibodies to BK virus30 Jun 2026US 12,668,620 B2Icahn School of Medicine at Mount Sinai
- Polyomavirus neutralizing antibodies16 Jun 2026US 12,653,885 B2Novartis AG
- Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same31 Mar 2026US 12,590,156 B2Ajou University Industry-Academic Cooperation Foundation
- Cell penetrating conjugates and methods of use thereof13 Jan 2026US 12,521,445 B2City of Hope
- Monoclonal antibodies against JC virus9 Sep 2025US 12,410,238 B2Icahn School of Medicine at Mount Sinai
- Dosing of polyomavirus neutralizing antibodies10 Sep 2026US 2026/0265346 A1Novartis AG
- Bkv neutralizing antibodies10 Sep 2026US 2026/0265347 A1Centre Hospitalier Universitaire Grenoble Alpes
- Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes12 Mar 2026US 2026/0070960 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Bk virus neutralizing antibodies11 Dec 2025US 2025/0376504 A1Centre Hospitalier Universitaire Grenoble Alpes
- Bk virus neutralizing antibodies11 Dec 2025US 2025/0376505 A1Centre Hospitalier Universitaire Grenoble Alpes
Most cited
By later US patents
- Diagnostic peptides of human papilloma virus73US 4,777,239 AThe Board of Trustees of the Leland Stanford Junior University · 1988
- Vaccine composition comprising herpes simplex virus and human papilloma virus antigens43US 6,936,255 B1SmithKline Beecham Biologicals s.a. · 2005
- Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion42US 5,439,829 AEli Lilly and Company · 1995
- Recombinant papilloma virus L142US 6,013,262 AThe University of Queensland · 2000
- Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes31US 5,932,412 AEuro-Diagnostica AB · 1999